Abstract
Background. KDOQI guidelines recommend preparation for renal replacement therapy (RRT) once stage 4 chronic kidney disease (CKD) is reached. Recent studies conducted in the general population and in patients referred to nephrologists have shown that CKD patients, especially the elderly, are much more likely to die than to reach RRT. We investigated whether futile preparation for RRT was performed in CKD patients referred to our nephrology department. Methods. We included all patients (n = 386) with stage 4 CKD and without prior RRT, seen at our outpatient clinic between 1 November 2004 and 30 April 2007. Demographics, clinical and laboratory data at inclusion were collected. Follow-up continued until 1 November 2007 or later (last appointment or study outcome). The primary outcome was death without requiring RRT, and secondary outcomes were RRT, going through our pre-dialysis education programme (PDEP) and undergoing the creation of an arterio-venous fistula (AVF). Factors predicting these outcomes were analysed. Results. During complete follow-up (average 23.4 months), 47 patients (12.1%) died without requiring RRT and 59 patients (15.3%) started RRT. The rate of death without requiring RRT in the overall cohort increased from 50 years onwards and exceeded that of RRT in incident patients aged ≥80 years. A structured PDEP was offered to 66.1% of patients starting RRT vs 14.9% of patients dying without requiring RRT and 13.9% of patients surviving without requiring RRT (P < 0.001). In addition, 53.3% of patients starting haemodialysis had a prior AVF creation vs 6.4% of patients
Introduction
Traditionally, once severe chronic kidney disease (CKD) is reached, the primary concern of both nephrologist and CKD patient is preparation for renal replacement therapy (RRT). This concern is in agreement with the NKF-KDOQI guidelines that recommend education and preparation for RRT once stage 4 CKD is attained [1] . Recent studies have, however, shown that CKD is an independent cardiovascular (CV) risk factor [2, 3] and that CKD subjects from the general population are much more likely to die than to reach endstage renal disease (ESRD) [4] [5] [6] [7] . This has also been recently observed in patients referred to nephrologists [8] [9] [10] [11] .
We studied the outcome of stage 4 CKD patients referred during a 2 ½-year inclusion period, or already followed at our renal clinic, in terms of death without requiring RRT or RRT initiation. We examined the proportion of patients having gone through our structured pre-dialysis education programme (PDEP) and having had an arterio-venous fistula (AVF) creation, and assessed the factors predicting these outcomes. Our hypothesis was that a substantial fraction of CKD 4 patients could have been unnecessarily prepared for RRT in our department.
Materials and methods

Patients
The study cohort was identified from the prospective local registry of CKD stage 4 patients referred to or followed by the outpatient renal clinic at the Cliniques Universitaires St Luc (Brussels, Belgium). All such patients were prospectively registered from 1 November 2004 onwards. For the present study, inclusion criteria were: adults (>18 years), CKD stage 4 (15 ≤ estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m 2 ) at baseline, no prior RRT and at least one visit at the clinic between 1 November 2004 and 31 April 2007. Patients referred for immediate initiation of dialysis were not included. Patients were considered as incident if referral at the renal clinic occurred after 1 November 2004 and as prevalent if not.
Methods
CKD was defined according to KDOQI: either kidney damage or eGFR <60 mL/min/1.73 m 2 for >3 months. eGFR was calculated using the abbreviated MDRD formula [12] .
Baseline characteristics included demographics (age, gender and ethnicity), lifestyle (history of smoking), medical history (aetiology of CKD, CV events, diabetes mellitus and neoplasia), medication use (antihypertensive agents, lipid-lowering agents and anti-platelet agents), physical examination [height, weight, body mass index (BMI), systolic and diastolic blood pressure] and laboratory results (haemoglobin, CRP, creatinine, phosphorus and 24-h proteinuria).
CV events included a history of coronary artery disease (myocardial infarction, coronary angioplasty or coronary artery bypass surgery), congestive heart failure, peripheral vascular disease (non-traumatic limb amputation, lower extremity bypass surgery or angioplasty) and cerebrovascular disease (stroke, carotid endarterectomy or angioplasty). Neoplasias included solid organ and haematopoietic cancers. Neoplasias were classified as past (complete remission) or active (whether under treatment or not) on the basis of medical records.
In our institution, patients progressing towards ESRD usually go through a structured PDEP aiming at providing information on all modalities of RRT and at promoting self-care RRT modalities [13] . This PDEP is a key step in the preparation for RRT.
Outcomes
The primary outcome was death without requiring RRT, and the secondary outcomes were RRT [haemodialysis (HD), peritoneal dialysis and preemptive renal transplantation], going through the PDEP and AVF creation prior to HD start. Follow-up continued until 1 November 2007 or later depending on the date of the last appointment or study outcome (death or RRT), to ensure a follow-up of at least 6 months in all patients. For patients lost to follow-up, general practitioners were contacted. When unsuccessful, patients or family were contacted by phone.
Statistics
In the univariate analysis, the comparison of proportions relied on the Chi-square test. The Wilcoxon rank sum test was used for the comparison of continuous variables, as they were not always normally distributed.
The deterioration rate of kidney function was measured by the difference between eGFR at outcome and eGFR at inclusion divided by the follow-up duration (in months). After logarithmic transformation, a multivariate linear regression analysis was used to identify the factors with a significant impact on this deterioration rate.
We looked for independent factors predictive of duration before death and of duration before RRT by using the Cox proportional hazards model in incident and prevalent patients. We chose a stepwise selection including variables when a P-value of 0.05 was attained. Explanatory variables introduced in the models were age, sex, history of smoking, diabetes, drugs (angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, lipid-lowering agent and anti-platelet agent), history of CV event, presence of active neoplasia, mean blood pressure, BMI, haemoglobin, CRP, eGFR, phosphorus, proteinuria and the interaction terms diabetes (= 1 if present or 0 if absent) × proteinuria and eGFR × proteinuria.
Logistic multivariate regression was used to test the impact of explanatory variables on preparation for RRT (as defined by going through the PDEP) and creation of AVF (the latter, after exclusion of patients started on PD). We also chose a stepwise selection including variables when a Pvalue of 0.05 was attained. Explanatory variables introduced in the models were the same as those used to identify factors predictive of duration before death and duration before RRT.
The analysis was made with SAS software version 9. A P-value of 0.05 was considered as significant.
Results
Baseline
Baseline characteristics of the overall cohort (n = 386), of prevalent and of incident patients are shown in Table 1 . Thirty percent of the cohort were diabetic, 60% were men and 98% were Caucasians. As compared with prevalent patients, incident ones were older, had a higher systolic and mean blood pressure, lower eGFR and haemoglobin levels, a higher prevalence of history of CV disease and a lower use of renin-angiotensin blockers.
Main outcomes
The outcome is known in all 386 patients. Prevalent patients had a longer follow-up (25.5 ± 11 months vs 19.5 ± 9 months, P < 0.001). During follow-up, 47 patients (12.2%) died before RRT, 20 of a CV cause, 5 of septicaemia, 11 of neoplasia and 11 of another or unknown aetiology. Fifty-nine patients (15.3%) started RRT [45 haemodialysis (11 self-care, 34 in-centre), 10 peritoneal dialysis and 4 pre-emptive transplantation]. Outcome was similar in prevalent and incident patients (P = 0.46) ( Table 1 , Supplementary data). More than two-thirds of patients experienced neither RRT nor death.
Outcomes as a function of age Figure 1 shows the proportion of death without requiring RRT, RRT and survival without RRT as a function of age for prevalent and incident patients. The proportion of patients dying without requiring RRT increases with age after 50 years and exceeds that of RRT in patients aged 80 years or more (P = 0.01) in the overall cohort. This was significant in incident patients (P = 0.02), but not in prevalent patients (P = 0.11).
In the group of deceased patients, the last eGFR was 21.1 ± 10.3 mL/min/1.73 m 2 , measured an average of 1.9 months before death. The eGFR before death was 21.2 ± 9.9 mL/ min/1.73 m 2 among patients <80 years old and 21.0 ± 10.8 mL/min/1.73 m 2 among patients ≥80 years old (P = 0.96), without difference between groups in the time interval between the last measure of eGFR and death. Four patients were considered as having died before RRT even though they underwent acute haemodialysis shortly before death. Acute renal failure (a not infrequent complication of CKD) [14] resulted from haemodynamic instability in three cases and from ureteral obstruction in one case. All four patients had baseline eGFR >15 mL/min/1.73 m 2 , stable during the 18 months preceding admission and on admission leading to death.
One patient (aged 91 years) consistently refused dialysis at the nephrology clinic; he died at home of unknown aetiology. Three prostatic adenocarcinomas, three small bowel carcinoid tumours, two pancreatic adenocarcinomas, one pancreatic neuroendocrine tumour, one clear cell renal carcinoma, one colorectal adenocarcinoma, one ampulloma, one breast adenocarcinoma, one squamous cell carcinoma of the cervix, one adenocarcinoma of unknown origin, one multiple myeloma. PKD = polycystic kidney disease, GN = glomerulonephritis, IN = interstitial nephropathy, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker.
Among patients starting RRT, eGFR at time of RRT initiation was 10.9 ± 2.0 mL/min/1.73 m 2 in the whole group, 10.1 ± 4.0 mL/min/1.73 m 2 in patients aged <80 years vs 10.9 ± 2.0 mL/min/1.73 m 2 in patients aged ≥80 years (P = 0.22).
Predictors of death
Independent factors predictive of shorter time before death in prevalent patients were active neoplasia [hazard ratio (HR) 8.84, 95% confidence interval (95% CI) 3.32-23.54, P =< 0.0001], a history of CV disease (HR 4.35, 95% CI 1.45-13.02, P = 0.01), older age (HR 1.08, 95% CI 1.03-1.13, P = 0.002), a low mean blood pressure (HR 0.97, 95% CI 0.94-1.00, P = 0.03) and high CRP (HR 1.17, 95% CI 1.04-1.31, P = 0.01). In incident patients, active neoplasia (HR 9.44, CI 2.37-37.59, P =< 0.0004) and older age (HR 1.07, CI 1.01-1.14, P = 0.02) were predictive of shorter time before death.
Predictors of eGFR decline
In the overall cohort, patients aged ≥80 years and patients aged <80 years had similar eGFR decline rates [median The outcome in terms of survival without requiring RRT, RRT initiation and death without requiring RRT is shown by age group for prevalent (P) and incident (I) patients. The proportion of patients dying before reaching RRT increases after 50 years. The rate of death prior to RRTexceeds that of RRT for patients aged ≥80 years (P = 0.01) in the overall cohort. This was significant in incident patients (P = 0.02), but not in prevalent patients (P = 0.11). /year in patients dying without requiring RRT (P =< 0.001).
Factors predicting a faster eGFR decline among prevalent patients were a high eGFR × proteinuria product, a high blood pressure and the absence of active neoplasia ( Table 2 , Supplementary data). The interaction between eGFR and proteinuria is illustrated in Figure 1 , Supplementary data. In incident patients, only a high diabetes × proteinuria product predicted faster eGFR decline, indicating a synergistic effect of proteinuria in diabetic patients (Table 2 , Supplementary data).
Predictors of RRT
Independent factors predictive of a shorter time before RRT in prevalent patients were a low eGFR (HR 0.80, 95% CI 0.72-0.89, P =< 0.0001), a high eGFR × proteinuria product (HR 1.03, 95% CI 1.02-1.05, P = 0.0002), a high phosphate level (HR 1.66, 95% CI 1.10-2.50, P = 0.02), a high mean blood pressure (HR 1.04, 95% CI 1.01-1.06, P = 0.006) and the absence of use of an antiplatelet agent (HR 0.19, 95% CI 0.06-0.64, P = 0.007). The interaction between eGFR and proteinuria was similar to that observed on the rate of decline of eGFR (Figure 1 , Supplementary data). In incident patients, a low eGFR (HR 0.89, 95% CI 0.81-0.99, P = 0.03) and a high diabetes × proteinuria product (HR 1.17, 95% CI 1.07-1.28, P = 0.0006) predicted a shorter time before RRT.
Predictors of exposure to PDEP
In the overall population, 85/386 patients (22%) went through the structured PDEP, mostly patients aged <80 years (24 vs 11% in patients aged ≥80 years, P = 0.02). A total of 66.1% of patients starting RRT had gone through the PDEP, vs only 14.9% of patients dying without requiring RRT and 13.9% of patients surviving without requiring RRT (P < 0.0001). Patients initiating self-care modalities had virtually all gone through PDEP vs only 50% of patients starting in-centre haemodialysis (17/34). Whatever the outcome considered (survival without requiring RRT, RRT or death), fewer patients aged ≥80 years went through PDEP than did those aged <80 years, but this was significant only in patients initiating RRT (33.3 vs 72.0%, P = 0.03).
Younger patients with higher mean blood pressure, lower BMI and lower eGFR had a higher probability of going through the PDEP ( Table 2) .
Predictors of AVF creation
Overall, 53.3% of patients starting haemodialysis had at least one prior creation of AVF vs 6.4% of patients dying without requiring RRT and 5.7% of patients surviving without RRT (P < 0.001). These figures were not statistically different between patients aged <80 or ≥80 years nor between prevalent and incident patients. Patients initiating haemodialysis all had at least one prior AVF creation if they had gone through the PDEP (28/28) vs only 6/17 (35.3%) if they had not gone through the PDEP (P < 0.001).
Factors predicting AVF creation in prevalent and incident patients are shown in Table 3 . In prevalent patients, lower eGFR, higher proteinuria and higher mean blood pressure predicted AVF creation. The only predictive factor of AVF creation in incident patients was a low eGFR.
Discussion
The first objective of our work was to describe the outcome of stage 4 CKD patients referred to our nephrology clinic in terms of survival and RRT. We report that the risk of starting RRT was superior to that of death prior to RRT in the overall cohort but was lower than the risk of death in patients aged ≥80 years, though this difference was significant in incident patients only. The common practice to offer dialysis to elderly patients in Belgium, a country with one of the highest intake rates on RRT [15] , and careful examination of medical records of deceased patients eliminate the possibility that RRT was not started because of old age and/or associated co-morbidities and that patients died as a result of kidney failure. Our findings are similar to those of O'Hare et al. who found that, among 209,622 US veterans with CKD stages 3-5 followed for a mean of 3.2 years, older patients had higher rates of death than ESRD, even at relatively low levels of eGFR [16] . This is due to the higher competing risk of death and more slowly progressive kidney diseases in older patients [9, 10, 16] , the latter not being confirmed in our cohort.
The ratio of the number of CKD patients referred to nephrologists who required RRT vs the number of those who died without requiring RRT has been highly variable in three previous studies: 3/1 in British Columbia (stages 4-5 CKD, first 2 years of follow-up), vs 1/2 in Northern Ireland and South-East Scotland (stage 4 CKD, median follow-up of 3.8 years), and 3.2/1 in Taiwan (stages 3-5 CKD, median follow-up of 2.3 years) [9] [10] [11] . Ethnic, age and co-morbidity differences probably account for most of this difference. Still, the first two studies concur with ours: older patients with low proteinuria are more likely to die than to require RRT [9, 10, 17] . Strong arguments point to the need for early preparation for RRT. Early dialysis education diminishes the proportion of urgent vs elective dialysis in CKD patients [18] . Unplanned dialysis initiation and temporary catheter use are associated with increased morbidity and mortality [19] . HBV vaccination, another part of RRT preparation, has recently been recommended from CKD stage 3 on [20] . Still our results and those of others [8] [9] [10] [11] show that preparation for RRT can be futile in subgroups of patients referred to nephrologists who are more likely to die than to reach ESRD. O'Hare et al. showed that if all their Veterans with an eGFR <25 mL/min/1.73 m 2 had been referred for AVF creation, there would have been a ratio of unnecessary to necessary procedures after 2 years of follow-up of 5:1 for patients aged 85-100 compared to 0.5:1 for those aged 18-44 years [21] . Furthermore, it has recently been suggested that conservative management may be more appropriate in elderly nursing home residents with ESRD [22] .
The second objective of our work was to examine whether a substantial fraction of our patients had been unnecessarily prepared for RRT. To our knowledge, this question had not yet been addressed in a current cohort of CKD stage 4 patients referred to nephrologists. Contrarily to what we hypothesized, only 14.9% of our patients underwent futile preparation for RRT (defined by PDEP followed by death). On the other hand, only 66.1% of patients starting RRT had been exposed to the PDEP and only 53.3% of patients starting haemodialysis had undergone prior AVF creation. Not surprisingly, younger age was a strong determinant of going through the PDEP, a finding reminiscent of our prior report of 40% of patients starting in-centre haemodialysis (mostly elderly and/or sick) without PDEP [13] .
A recent prospective study by Wu et al. showed a significant reduction in the incidence of dialysis and mortality in CKD patients (eGFR <60 mL/min/1.73 m 2 ) exposed to multidisciplinary pre-dialysis education (MPE) [23] . However, MPE was an integrated course involving individual lectures on renal health (nutrition, lifestyle, nephrotoxin avoidance and pharmacological regimens), with CKD stage-based approaches. Nurses contacted all patients to ensure timely follow-up. In our centre, patients are referred to the PDEP nursing team to get detailed information on treatment modalities in order to decrease anxiety and promote self-care RRT modalities. The nephrologist then continues to follow the patient until RRT initiation [13] . Our PDEP is thus more restrictive than a MPE: patients are referred to the PDEP only when the nephrologist feels that the patient will be starting RRT in the relatively 'near' future. Only 20% of our CKD 4 patients went through the PDEP. In a recent editorial, Van Biesen et al. encourage the implementation of MPE in all CKD programmes but state that this is labour intensive and that cost-effectiveness evaluation is lacking [24] . We are currently considering a MPE along these lines.
Overall, it is important to better identify patients who will probably reach ESRD and hence benefit from preparation for RRT, though most patients will probably benefit from a MPE. We identified a high eGFR × proteinuria product, a high diabetes × proteinuria product, a low eGFR and a high mean blood pressure as factors predicting a faster rate of decline of eGFR and/or a shorter duration before RRT. A low eGFR, a high mean blood pressure and a high proteinuria were also predictors of exposure to PDEP and AVF fistula creation: nephrologists relied on these classical factors to identify patients most likely to benefit from preparation for RRT. The positive interaction between eGFR and proteinuria on renal outcome has already been found in the general population-based HUNT-2 study [25] , but not in diabetics in the ADVANCE study [26] .
An individual assessment of risk factors for progression towards ESRD vs death could help the nephrologist to avoid futile preparation for RRT but probably at the expense of poor preparation of some patients who eventually require RRT. In our study, only 35.3% of patients starting HD had at least one prior AVF creation if they had not been exposed to PDEP, demonstrating the difficulty of correctly identifying patients most likely to benefit from preparation for RRT.
The strengths of our study are the complete follow-up (no patient lost), the detailed co-morbidity available from medical records and the single-centre design, with biological tests all analysed in the same laboratory. As mentioned above, to our knowledge, we are the first to have studied the proportion of patients with CKD stage 4 prepared for RRT in a current cohort of CKD patients referred to nephrologists. Several limitations have to be acknowledged. The referral pattern associated with the Belgian Healthcare system and the academic setting may make our results not fully applicable to other countries or populations. The MDRD formula has not been validated in the elderly. Finally, the follow-up is shorter than in recent studies having examined outcome in terms of death without requiring RRT and RRT initiation in CKD patients referred to nephrologists [9] [10] [11] .
Conclusion
Overall, we propose that CKD stage-based approaches should be revised in the light of recent studies, including ours, showing a high mortality rate in subgroups of CKD patients referred to nephrologists, such as the elderly and patients with a known CV history. Preparation for RRT in patients aged ≥80 years should be more readily considered if patients have no or few co-morbidities (especially CV) and if eGFR is <20 mL/min/1.73 m 2 and/or there is rapid CKD progression. Our strategy was able to avoid most of the futility that could have resulted from the indiscriminate application of the NKF-KDOQI guidelines. This was, however, obtained at the expense of incomplete exposure of patients who eventually started RRT to the structured PDEP and only 53% level of AVF created at start of HD. Whether and how these figures can be improved will require further investigation.
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